Aeglea BioTherapeutics | TalkMarkets | Page 1
No data available
No data available

People who follow this stock (30)

View All

Latest Posts

About This Stock More About This Stock
The Week Ahead In Biotech: Cardiology, Analyst Conferences In The Spotlight
Article By: Benzinga
Monday, September 2, 2019 3:30 PM EDT
The biotech space saw muted activity in the week ended Aug. 30.
In this article: AZN, JNJ, RHHBY, ALNY, PSTV, AMGN, CELG, MDCO, IONS, AGLE, ANAB, AKCA, ZLAB
Read
Puma (PBYI) Q1 Loss Narrows, Focus Remains On Neratinib
Article By: Zacks Investment Research
Thursday, May 11, 2017 10:10 AM EDT
Puma Biotechnology, Inc. reported a first-quarter 2017 loss of $1.97 per share narrower than the Zacks Consensus Estimate of a loss of $2.08 and the year-ago loss of $2.19.
In this article: PBYI Also: AGLE, AKTX
Read
All Posts

Latest Tweets for $AGLE

No tweets yet!

PARTNER HEADLINES